{
    "2018-09-26": [
        [
            {
                "time": "2018-09-27",
                "original_text": "Prestige Consumer Healthcare Inc. (PBH) Ex-Dividend Date Scheduled for September 27, 2018",
                "features": {
                    "keywords": [
                        "Ex-Dividend",
                        "Prestige Consumer Healthcare",
                        "Scheduled"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-26",
                "original_text": "Glaxo's Tuberculosis Vaccine Positive in Mid-Stage Study",
                "features": {
                    "keywords": [
                        "Tuberculosis",
                        "Vaccine",
                        "Positive",
                        "Mid-Stage Study"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-26",
                "original_text": "What’s Driving Pfizer’s Revenue?",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Revenue",
                        "Driving"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-26",
                "original_text": "The Zacks Analyst Blog Highlights: Johnson & Johnson, Visa, Verizon, Alphabet and Altria",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst",
                        "Blog",
                        "Johnson & Johnson",
                        "Visa",
                        "Verizon",
                        "Alphabet",
                        "Altria"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "technology",
                        "telecommunications",
                        "consumer goods"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-26",
                "original_text": "J&J exec: Tuberculosis is a global emergency. It's time to start treating it that way.",
                "features": {
                    "keywords": [
                        "J&J",
                        "Tuberculosis",
                        "global emergency",
                        "treating"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-26",
                "original_text": "What Johnson & Johnson Expects for Xarelto",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Xarelto",
                        "Expects"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-26",
                "original_text": "Opportunities and Competition for J&J’s Blockbuster Drug, Xarelto",
                "features": {
                    "keywords": [
                        "Opportunities",
                        "Competition",
                        "J&J",
                        "Blockbuster Drug",
                        "Xarelto"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-26",
                "original_text": "Market Morning: Treasury Bear, Fed Fuss, Square FANGAS, And Dunkin’ Not Donuts",
                "features": {
                    "keywords": [
                        "Market Morning",
                        "Treasury Bear",
                        "Fed Fuss",
                        "Square",
                        "FANGAS",
                        "Dunkin'"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "technology",
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-09-26",
                "original_text": "DAX Subdued Ahead Of Fed Decision",
                "features": {
                    "keywords": [
                        "DAX",
                        "Subdued",
                        "Fed Decision"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}